课题基金 / 基金详情

An evaluation of patient reported outcomes, patterns of symptoms severity, survival and healthcare costs for neuroendocrine tumours (NETs).

An evaluation of patient reported outcomes, patterns of symptoms severity, survival and healthcare costs for neuroendocrine tumours (NETs).
对患者报告的神经内分泌肿瘤 (NET) 的结果、症状严重程度、生存率和医疗费用进行评估。
批准号：
388354
负责人：
Hallet Julie
金额：
$18.11万
依托单位：
Sunnybrook Research Institute (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-09-01 至 2021-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=388354&lang=en
关键词：
Cancer Cancer Treatment Care Effectiveness Neuroendocrine Tumours Patient Reported Outcomes Patient-Centred Care Population Health Survival

项目摘要

项目成果

Hallet Julie的其他基金

相似基金

相关文献

中文摘要
翻译
神经内分泌肿瘤（NETs）是增长最快的癌症之一。它们可以出现在任何器官，但最常见于胃，肠，胰腺和肺。它们是生长缓慢的肿瘤，可以分泌激素，产生衰弱的症状。Ove
英文摘要
Neuronendocrine tumors (NETs) are one of the fastest growing cancers. They can arise in any organ, but most commonly in the stomach, intestine, pancreas, and lungs. They are slow growing tumors that can secrete hormones creating debilitating symptoms. Ove
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Addressing variation in practice in red blood cells transfusion for patients undergoing gastrointestinal cancer surgery.
Understanding and predicting long-term outcomes of older adults undergoing cancer surgery
海外基金